The End Game

Mastering the Lab Sale: Strategic Timing and Preparation

8 min · 5. maj 2026
Billede af episoden Mastering the Lab Sale: Strategic Timing and Preparation

Description

In this episode of The End Game, Melissa Butterworth explores the strategic timing behind selling a laboratory, highlighting the key factors that can significantly impact valuation. She discusses the importance of thorough preparation, maintaining strong operational performance, understanding market conditions, and assessing personal readiness. The episode underscores that a successful exit isn’t just about when you sell—but how well-positioned your business is when you do

Comments

0

Be the first to comment

Sign up now and become a member of the The End Game community!

Start for free

Start 14 days free trial

99 kr. / month after trial. · Cancel anytime

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

55 episodes

episode The Future of Alzheimer's Diagnosis: How Blood-Based Biomarkers Are Changing Care artwork

The Future of Alzheimer's Diagnosis: How Blood-Based Biomarkers Are Changing Care

The future of Alzheimer's diagnosis is here—and it's happening with a simple blood test. In this episode, we explore how blood-based biomarkers are transforming the detection and management of Alzheimer's disease. Learn how innovative tests measuring biomarkers like P-TAU217 are providing highly accurate, less invasive alternatives to traditional PET scans and cerebrospinal fluid testing, making earlier diagnosis more accessible than ever. We also discuss the critical role clinical laboratories play in implementing these advanced diagnostic technologies, the infrastructure required to support high-sensitivity testing, and how labs are helping monitor the effectiveness and safety of emerging Alzheimer's therapies. As personalized medicine continues to evolve, laboratory diagnostics are becoming an essential part of improving patient outcomes and supporting long-term disease management. In this episode, you'll learn: * How blood-based biomarkers are changing Alzheimer's diagnosis * Why P-TAU217 is emerging as a key diagnostic marker * The shift from imaging to serum-based testing * Laboratory challenges and opportunities in high-sensitivity diagnostics * How blood tests are supporting personalized treatment monitoring for Alzheimer's patients Whether you're a laboratory professional, healthcare leader, or simply interested in the latest advancements in diagnostic medicine, this episode offers valuable insights into one of the fastest-growing areas of laboratory innovation.

13. aug. 20266 min